95 related articles for article (PubMed ID: 27922905)
1. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
[TBL] [Abstract][Full Text] [Related]
2. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
[TBL] [Abstract][Full Text] [Related]
3. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
[TBL] [Abstract][Full Text] [Related]
6. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
[TBL] [Abstract][Full Text] [Related]
9. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
10. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of self-collected human papillomavirus specimens as a primary screen for cervical cancer.
Quincy BL; Turbow DJ; Dabinett LN; Dillingham R; Monroe S
J Obstet Gynaecol; 2012 Nov; 32(8):795-9. PubMed ID: 23075359
[TBL] [Abstract][Full Text] [Related]
12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
13. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA.
Reiter PL; McRee AL
J Fam Plann Reprod Health Care; 2015 Oct; 41(4):259-64. PubMed ID: 25385868
[TBL] [Abstract][Full Text] [Related]
15. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
16. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
17. Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population.
Chen K; Ouyang Y; Hillemanns P; Jentschke M
J Obstet Gynaecol Res; 2016 Dec; 42(12):1839-1845. PubMed ID: 27647799
[TBL] [Abstract][Full Text] [Related]
18. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
Racey CS; Gesink DC
J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
[TBL] [Abstract][Full Text] [Related]
19. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
20. Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
Coldman AJ; Phillips N; van Niekerk D; Smith L; Krajden M; Cook D; Quinlan DJ; Ehlen T; Miller D; Stuart GC; Peacock S; Martin RE; Franco EL; Ogilvie G
J Obstet Gynaecol Can; 2015 May; 37(5):412-420. PubMed ID: 26168101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]